mono-n-octyl phthalate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blangero, J; Curran, JE; Kulkarni, H; Mamtani, M | 1 |
1 other study(ies) available for mono-n-octyl phthalate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Association of Urinary Phthalates with Self-Reported Eye Affliction/Retinopathy in Individuals with Diabetes: National Health and Nutrition Examination Survey, 2001-2010.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dose-Response Relationship, Drug; Environmental Exposure; Female; Humans; Male; Middle Aged; Nutrition Surveys; Phthalic Acids; Risk Assessment; Risk Factors; Self Report; Time Factors; United States; Urinalysis | 2016 |